UPB
UPB
NASDAQ · Biotechnology

Upstream Bio Inc

$3.70
+0.31 (+9.14%)
As of Nov 7, 1:49 AM ET ·
Financial Highlights (FY 2026)
Revenue
2.39M
Net Income
-119,941,979
Gross Margin
—
Profit Margin
-5,026.0%
Rev Growth
+33.0%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 67.3% 67.3%
Operating Margin -5,618.8% -5,056.9% -2.1% -2.1%
Profit Margin -5,026.0% -4,774.7% -1.8% -2.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.39M 1.79M 177.59M 201.20M
Gross Profit — — 119.60M 135.50M
Operating Income -134,098,252 -90,715,895 -3,738,401 -4,294,140
Net Income -119,941,979 -81,139,342 -3,219,143 -4,334,728
Gross Margin — — 67.3% 67.3%
Operating Margin -5,618.8% -5,056.9% -2.1% -2.1%
Profit Margin -5,026.0% -4,774.7% -1.8% -2.2%
Rev Growth +33.0% +33.0% -5.8% +19.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 530.13M 598.50M
Total Equity — — 856.80M 928.50M
D/E Ratio — — 0.62 0.64
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -133,932,809 -95,637,528 -5,179,349 -6,300,639
Free Cash Flow — — -3,332,995 -3,816,597